Successful treatment of an invasive growth hormone-secreting pituitary macroadenoma in an 8 year-old boy

Journal of Pediatric Endocrinology and Metabolism

Volumn 20, Issue 5, 2007, Pages 643-647

  Bowden, Sasigarn A ^a   Sotos, Juan F ^a   Stratakis, Constantine A ^b   Weil, Robert J ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Acromegaly; Gigantism; Growth hormone receptor antagonist; Microsurgery; Radiotherapy; Somatostatin analog

Indexed keywords

GROWTH HORMONE; OCTREOTIDE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACTH SECRETING ADENOMA; ARTICLE; BODY HEIGHT; BONE AGE; CANCER INVASION; CASE REPORT; CAVERNOUS SINUS; DIARRHEA; DRUG DOSE REDUCTION; FOLLOW UP; GROWTH ACCELERATION; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRECOCIOUS PUBERTY; SCHOOL CHILD; SEXUAL MATURATION; TRANSSPHENOIDAL HYPOPHYSECTOMY;

EID: 34250759877     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2007.20.5.643     Document Type: Article

References (19)

1. Thorner MO, Vance ML, Laws ER Jr, Horvath E, Kovacs K. The anterior pituitary. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams Textbook of Endocrinology, 9th Ed. Philadelphia, PA: W.B. Saunders Co., 1998; 295-302.
2. Oldfield EH, Vortmeyer AO. Development of a histological pseudocapsule and its use as a surgical capsule in the excision of pituitary tumors. J Neurosurg 2006; 104: 7-19.
3. Ahmed S, Elsheikh M, Stratton IM, Page RC, Adams CBT, Wass JAH. Outcome of transsphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol (Oxf) 1999; 50: 561-567.
4. Sheaves R, Jenkins P, Blackburn P, Huneidi AH, Afshar F, Medbak S, Grossman AB, Besser GM, Wass JA. Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure. Clin Endocrinol (OxF) 1996; 45: 407-413.
5. Laws ER, Jane JA Jr. Neurosurgical approach to treating pituitary adenomas. Growth Horm IGF Res 2005; 15 (Suppl A): S36-41.
6. Jaffe CA. Reevaluation of conventional pituitary irradiation in the therapy of acromegaly. Pituitary 1999; 2: 55-62.
7. Sheehan JP, Jagannathan J, Pouratian N, Steiner L. Stereotactic radiosurgery for pituitary adenomas: a review of the literature and our experience. Front Horm Res 2006; 34: 185-205.
8. Paisley AN, Drake WM. Treatment of pituitary tumors: pegvisomant. Endocrine 2005; 28: 111-114.
9. Colao A, Pivonello R, Auriemma RS, De Martino MC, Bidlingmaier M, Briganti F, Tortora F, Burman P, Kourides IA, Strasburger CJ, Lombardi G. Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance. Eur J Endocrinol 2006; 154: 467-477.
10. Oshino S, Saitoh Y, Kasayama S, Arita N, Ohnishi T, Kohara H, Izumoto S, Yoshimine T. Short-term pre-operative octreotide treatment of GH-secreting pituitary adenoma: predictors of tumor shrinkage. Endocr J 2006; 53: 125-132.
11. Bevan JS. The anti-tumoral effects of somatostatin analog therapy in acromegaly. J Clin Endocrinol Metab 2004; 90: 1856-1863.
12. Melmed S, Casanueva FF, Cavagnini F, Chanson P, Fronhman L, Grossman A, Ho K, Kleinberg D, Lamberts S, Laws E, Lombardi G, Vance ML, Werder KV, Wass J, Giustina A. 2002 Guidelines for acromegaly management. J Clin Endocrinol Metab 2002; 87: 4054-4058.
13. Donangelo I, Melmed S. Treatment of acromegaly: future. Endocrine 2005; 28: 123-128.
14. Katznelson L. Diagnosis and treatment of acromegaly. Growth Horm IGF Res 2005; 15 (Suppl A): 531-5.
15. Abe T, Ludecke DK. Effects of pre-operative octreotide treatment on different subtypes of 90 growth hormone secreting pituitary adenomas and outcome in one surgical center. Eur J Endocrinol 2001; 145: 137-145.
16. Lucas-Morante T, Garcia-Uria J, Estrada J, Saucedo G, Cabello A, Alcaniz J, Barcelo B. Treatment of invasive growth hormone pituitary adenomas with long-acting somatostatin analog SMS 201-995 before transsphenoidal surgery. J Neurosurg 1994; 81: 10-14.
17. Stevenaert A, Beckers A. Presurgical octreotide: treatment in acromegaly. Metabolism 1996; 45: 72-74.
18. Gelber SJ, Heffez DS, Donohoue PA. Pituitary gigantism caused by growth hormone excess from infancy. J Pediatr 1992; 120: 931-934.
19. Minagawa M, Yasuda T, Someya T, Kohno Y, Saeki N, Hashimoto Y. Effects of octreotide infusion, surgery and estrogen on suppression of height increase and 20K growth hormone ratio in a girl with gigantism due to a growth hormone-secreting macroadenoma. Horm Res 2000; 53: 157-160.